title: Prognosis: Proportionate response.
authors.forename: Sarah
authors.initials: S
authors.lastname: DeWeerdt
mesh_terms: D000951:Antigens, Neoplasm / Q000652:urine; D014408:Biomarkers, Tumor / Q000097:blood / Q000652:urine; D003955:Diagnostic Tests, Routine / Q000379:methods* / Q000639:trends; D006801:Humans; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000652:urine; D057285:Precision Medicine / Q000379:methods*; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000473:pathology / Q000652:urine; D018570:Risk Assessment
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D015514:Oncogene Proteins, Fusion; C515553:TMPRSS2-ERG fusion protein, human; C479341:prostate cancer antigen 3, human; D017430:Prostate-Specific Antigen